[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337448-105":59,"doc-detail-337448-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","idhwt-glioblastomas-can-be-stratified-by-their-transcriptional-response-to-standard-treatment-implications-for-targeted-therapy","IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment - Implications for targeted therapy","","Glioblastoma (GBM) brain tumors lacking IDH1 mutations (IDHwt) have the poorest prognosis. After surgery and chemoradiotherapy with temozolomide, local recurrence is almost inevitable, driving the need to understand treatment survival mechanisms. Using RNA-seq from 107 paired pre- and post-treatment locally recurrent IDHwt tumors, two longitudinal responder subtypes are defined, reflecting distinct adaptive resistance programs and tumor microenvironment changes. Subtype stratification may improve targeted treatment strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/idhwt-glioblastomas-can-be-stratified-by-their-transcriptional-response-to-standard-treatment-implications-for-targeted-therapy/337448/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/idhwt-glioblastomas-can-be-stratified-by-their-transcriptional-response-to-standard-treatment-implications-for-targeted-therapy/337448.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in IDHwt glioblastoma?","Question",{"text":112,"@type":113},"It addresses why IDH1-mutant-negative (IDHwt) GBM tumors almost always recur after surgery and chemoradiotherapy, leading to fatal outcomes despite standard care.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are responders classified in the study?",{"text":117,"@type":113},"Responder subtypes are identified using longitudinal RNA-seq from paired pre- and post-standard treatment recurrent tumors, based on upregulation versus downregulation of a specific gene subset from primary to recurrence.",{"name":119,"@type":110,"acceptedAnswer":120},"What microenvironment changes distinguish the responder subtypes?",{"text":121,"@type":113},"Up responders show enrichment in quiescent proneural GBM stem cells and differentiated neoplastic cells with increased interaction with surrounding normal brain and neurotransmitter signaling, while down responders commonly undergo mesenchymal transition.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337448,1790186574,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Tanner et al. Genome Biology (2024) 25:45 [https://doi.org/10.1186/s13059-024-03172-3](https://doi.org/10.1186/s13059-024-03172-3)  \nGenome Biology  \nRESEARCH Open Access  \nIDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapy  \nGeorgette Tanner1†, Rhiannon Barrow 1†, Shoaib Ajaib1, Muna Al‑Jabri1, Nazia Ahmed1, Steven Pollock 1, Martina Finetti 1, Nora Rippaus 1, Alexander F. Bruns2, Khaja Syed3, James A. Poulter 1, Laura Matthews 1, Thomas Hughes1,4, Erica Wilson1, Colin Johnson1, Frederick S. Varn5, Anke Brüning‑Richardson6, Catherine Hogg1, Alastair Droop7, Arief Gusnanto8, Matthew A. Care 1, Luisa Cutillo8, David R. Westhead9, Susan C. Short 1,10, Michael D. Jenkinson3,11, Andrew Brodbelt3, Aruna Chakrabarty10, Azzam Ismail 10, Roel G. W. Verhaak5,12 and Lucy F. Stead 1*  \n\n| †Georgette Tanner and Rhiannon Barrow contributed equally to this work. |\n| --- |\n| *Correspondence: [l.f.stead@leeds.ac.uk](l.f.stead@leeds.ac.uk) |\n\n1 Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds, UK  \nFull list of author information is available at the end of the article  \nAbstract  \nBackground: Glioblastoma (GBM) brain tumors lacking IDH1 mutations (IDHwt) have the worst prognosis of all brain neoplasms. Patients receive surgery and chemoradio‑ therapy but tumors almost always fatally recur.  \nResults: Using RNA sequencing data from 107 pairs of pre‑ and post‑standard treat‑ ment locally recurrent IDHwt GBM tumors, we identify two responder subtypes based on longitudinal changes in gene expression. In two thirds of patients, a specific subset of genes is upregulated from primary to recurrence (Up responders), and in one third, the same genes are downregulated (Down responders), specifically in neoplastic cells. Characterization of the responder subtypes indicates subtype‑specific adaptive treat‑ ment resistance mechanisms that are associated with distinct changes in the tumor microenvironment. In Up responders, recurrent tumors are enriched in quiescent proneural GBM stem cells and differentiated neoplastic cells, with increased interac‑ tion with the surrounding normal brain and neurotransmitter signaling, whereas Down responders commonly undergo mesenchymal transition. ChIP‑sequencing data from longitudinal GBM tumors suggests that the observed transcriptional reprogram‑ ming could be driven by Polycomb‑based chromatin remodeling rather than DNA methylation.  \nConclusions: We show that the responder subtype is cancer‑cell intrinsic, recapitu‑ lated in in vitro GBM cell models, and influenced by the presence of the tumor micro‑ environment. Stratifying GBM tumors by responder subtype may lead to more effective treatment.  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the mate‑ rial. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://](http://)[ ](http://)[creativecommons.org/licenses/by/4.0/](creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publi)[. The Creative Commons Public Domain Dedication waiver (](creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publi)[http://creativecommons.org","cbCaie8xiNqt276a","https://ap.wps.com/l/cbCaie8xiNqt276a","pdf",5189969,29,"English","# Abstract\n## Background\n## Results\n## Conclusions\n# Background\n## Clinical context and treatment challenge","[{\"question\":\"What problem does the study address in IDHwt glioblastoma?\",\"answer\":\"It addresses why IDH1-mutant-negative (IDHwt) GBM tumors almost always recur after surgery and chemoradiotherapy, leading to fatal outcomes despite standard care.\"},{\"question\":\"How are responders classified in the study?\",\"answer\":\"Responder subtypes are identified using longitudinal RNA-seq from paired pre- and post-standard treatment recurrent tumors, based on upregulation versus downregulation of a specific gene subset from primary to recurrence.\"},{\"question\":\"What microenvironment changes distinguish the responder subtypes?\",\"answer\":\"Up responders show enrichment in quiescent proneural GBM stem cells and differentiated neoplastic cells with increased interaction with surrounding normal brain and neurotransmitter signaling, while down responders commonly undergo mesenchymal transition.\"}]","IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment - Implications for targeted therapy | PDF",1790019189,73,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c631ae1ec9ba7e06c066bb6717f44a7.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42c03671612c64be45f087b45f4c034c.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a15c7d2d6913d240c7b40363b62902c5.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2baae1e4da13ccdc322e88755366a182.webp",980,1301]